Product Information
FLUOXETINE HCL 40 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0499 per EA under NDC 65862019405. Its NADAC has been published 654 times since Feb 12, 2014.
FDA first approved this application on Jan 31, 2008. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862019405
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078619FDA Approved
1/31/2008
TE Code
AB1
On Market Since
1/31/2008
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 40 MG CAPSULE has been published 654 times since Feb 12, 2014, and over the history we have for it it has declined 79.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0499 per EA |
|---|---|
| All-time high | $0.2459 (Feb 12, 2014) |
| All-time low | $0.0453 (Nov 20, 2024) |
| 52-week high | $0.0673 |
| 52-week low | $0.0499 |
| Median price | $0.0815 |
| Average price | $0.1084 |
| Largest weekly change | -35.9% (Nov 20, 2024) |
| Weeks tracked | 654 |
| Tracking since | Feb 12, 2014 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 40 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0499 per EA (NDC 65862019405), effective Aug 19, 2026.
How has the price of FLUOXETINE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has declined 79.7%. It has been tracked across 654 weekly CMS publications since Feb 12, 2014.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 40 MG CAPSULE?
Since Feb 12, 2014, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has ranged from a low of $0.0453 (Nov 20, 2024) to a high of $0.2459 (Feb 12, 2014), with a median of $0.0815 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 40 MG CAPSULE?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 40 MG CAPSULE?
FLUOXETINE HCL 40 MG CAPSULE (NDC 65862019405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.